Current news of SHS and our portfolio companies

13 September 2022 - Press Releases

MEDTECH-INSIDE – Part 17: Financing in Medtech SMEs

Medium-sized medical technology companies are facing many challenges in these geopolitically turbulent times: Supply chain problems, the MDR medical device regulation, digitalisation, energy shortages and rising refinancing costs due to the jump in interest rates. It’s good to have a solid capital base.

18 August 2022 - SHS News

SHS appoints Manfred Ulmer-Weber to the Management Board

Tübingen / 18.08.2022 Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft für Beteiligungsmanagement mbH. Ulmer-Weber will be jointly responsible for the allocation of the new SHS VI fund of the Tübingen-based sector specialist. The additional Managing Partner is an SHS home-grown and started his career at SHS in 2010. The shareholders […]

18 July 2022 - SHS News

More than 220 million euros for growth and succession investments in European healthcare companies. SHS launches sixth fund generation and exceeds target volume already in first closing

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of 200 million euros at the first closing. The sixth SHS fund generation also aims at majority and minority investments in the […]

16 May 2022 - Press Releases

MEDTECH-INSIDE – Part 16: Germany leads in DiGA

Digital health applications (DiGA) can improve medical care.

9 May 2022 - SHS News

SHS strengthens finance team: Lukas Maucher joins Tübingen-based private equity investor as CFO

Before joining SHS, Lukas worked as a manager at one of the Big Four auditing firms in southern Germany. He completed his Bachelor of Science in Business Administration with a focus on Corporate Accounting and Finance at the LMU in Munich. He completed his Master’s degree at the University of Mannheim with a focus on […]

22 April 2022 - SHS News

SHS and yabeo invest in the leading Scandinavian digital health platform Dr.Dropin

The fast-growing Norwegian healthcare provider Dropin enables short-term medical consultation and treatment – in person on site as well as digitally via app Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more than 100% for the last three years SHS invests from its fifth fund generation in the Scandinavian […]

21 April 2022 - SHS News

SHS sells shares in Bochum-based phenox GmbH, a leading manufacturer of instruments and implants for the treatment of stroke

The fast-growing MedTech company phenox specialises in instruments and implants for the neurointerventional therapy of stroke With the growth capital provided by SHS et al., the Bochum-based company has developed from a start-up into a global leader in the field of stroke therapy A successful exit for investors from the third SHS fund generation The […]

14 April 2022 - Press Releases

Institutional Money interview with SHS Managing Director Hubertus Leonhardt: Five ways to invest in medicine, pharma and healthcare

With the Corona pandemic, the healthcare sector, among others, has become the focus of increased attention among investors. SHS in Tübingen, an investment company specialising in the healthcare sector, outlines the asset classes that can be used to track such stocks.  

6 April 2022 - Press Releases

M&A Review interview with SHS Managing Partner Sascha Alilovic: “Germany has a large number of hidden champions”

The healthcare sector has come under increased public scrutiny as a result of the Corona pandemic. M&A deals in the sector have reached a high level in 2021. Many lighthouse companies, however, choose the US market for the participation of an investor or the IPO. Funders like SHS Gesellschaft für Beteiligungsmanagement mbH also offer companies […]

9 March 2022 - Press Releases

With capital, sector expertise, experience and a strong network, the healthcare investor SHS supports companies on their growth path.

Since 1993, the Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH has successfully developed and sold more than 68 companies from the medtech industry with capital and know-how. Read three success stories from our contribution to the Voelker brochure “Potentials MedTech 2022”, in which big names in medical technology have their say.